Muhammad Sulman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Sulman has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Allan R. Martin
Department of Neurosurgery, University of California, Davis, 4610 X Street, Sacramento, CA 95817, USA
2 shared publications - John Paul Aboubechara
University of California Davis
2 shared publications Khadija Soufi
2 shared publicationsOmar Ortuno
2 shared publications- Orwa Aboud
University of California Davis
2 shared publications Alan Harris
1 shared publication
Latest Publications
- Open Access
- 13 June 2026
- Published by Springer Nature in Journal of Neuro-Oncology Discovery
- Vol. 1 (1)
Sex-stratified evaluation of immune and cell cycle transcriptional programs in lower grade glioma
Purpose: Sex influences the incidence, molecular characteristics and clinical outcomes of gliomas, but the biological pathways contributing to these differences are not fully understood. In lower grade glioma (LGG), immune activity and cell cycle dysregulation are key components of tumor behavior. Because sex heavily influences baseline survival, it is critical to determine if the prognostic relevance of these transcriptional programs differs between males and females, or if they offer universal utility. This study evaluated the robustness of immune and cell cycle gene expression signatures as prognostic markers across sex-stratified cohorts in LGG using data from The Cancer Genome Atlas (TCGA). Methods: Clinical and Ribonucleic acid (RNA) sequencing data from 510 patients with lower grade glioma in The Cancer Genome Atlas were analyzed. Only primary tumors with complete information on survival, age, sex, grade and primary diagnosis were included. Raw RNA counts were normalized to log-counts per million using the trimmed mean of M values (TMM) method in edgeR. Two predefined transcriptional signatures were examined: an immune activation signature (CD3D, CD3E, CD8A, CXCL9, CXCL10, GZMB, PDCD1) and a cell cycle proliferation signature (MKI67, PCNA, TOP2A, CCNB1, CDK1, BIRC5). Signature scores were calculated as the mean expression of component genes, standardized to z-scores, and categorized into within-sex tertiles. Associations with overall survival were evaluated using Kaplan–Meier curves and multivariable Cox proportional hazards models. Models adjusted for age and grade included interaction terms to evaluate whether prognostic utility varied by sex. Results: Higher immune and cell cycle signature scores were each associated with shorter overall survival (immune: log-rank p = 0.0028; cell cycle: p < 0.0001). In multivariable Cox models adjusted for age and grade, both signatures remained independently associated with mortality (immune HR per SD = 1.58, 95% CI 1.25–2.00; cell-cycle HR = 1.47, 95% CI 1.15–1.89). Crucially, interaction analyses indicated that the prognostic impact of these signatures did not significantly differ between sexes, demonstrating consistent adverse associations across both male and female cohorts. Conclusion: Immune and cell cycle transcriptional programs show robust, independent associations with survival in lower grade glioma that are consistent across sexes. Elevated activity in either pathway is universally linked to poorer outcomes. These findings validate the broad prognostic utility of these transcriptional signatures in LGG, highlighting their potential clinical relevance regardless of patient sex.
- 13 June 2026
- Published by Springer Nature in Journal of Neuro-Oncology Discovery
- Vol. 1 (1)
Open AccessSex-stratified evaluation of immune and cell cycle transcriptional programs in lower grade glioma
Purpose: Sex influences the incidence, molecular characteristics and clinical outcomes of gliomas, but the biological pathways contributing to these differences are not fully understood. In lower grade glioma (LGG), immune activity and cell cycle dysregulation are key components of tumor behavior. Because sex heavily influences baseline survival, it is critical to determine if the prognostic relevance of these transcriptional programs differs between males and females, or if they offer universal utility. This study evaluated the robustness of immune and cell cycle gene expression signatures as prognostic markers across sex-stratified cohorts in LGG using data from The Cancer Genome Atlas (TCGA). Methods: Clinical and Ribonucleic acid (RNA) sequencing data from 510 patients with lower grade glioma in The Cancer Genome Atlas were analyzed. Only primary tumors with complete information on survival, age, sex, grade and primary diagnosis were included. Raw RNA counts were normalized to log-counts per million using the trimmed mean of M values (TMM) method in edgeR. Two predefined transcriptional signatures were examined: an immune activation signature (CD3D, CD3E, CD8A, CXCL9, CXCL10, GZMB, PDCD1) and a cell cycle proliferation signature (MKI67, PCNA, TOP2A, CCNB1, CDK1, BIRC5). Signature scores were calculated as the mean expression of component genes, standardized to z-scores, and categorized into within-sex tertiles. Associations with overall survival were evaluated using Kaplan–Meier curves and multivariable Cox proportional hazards models. Models adjusted for age and grade included interaction terms to evaluate whether prognostic utility varied by sex. Results: Higher immune and cell cycle signature scores were each associated with shorter overall survival (immune: log-rank p = 0.0028; cell cycle: p < 0.0001). In multivariable Cox models adjusted for age and grade, both signatures remained independently associated with mortality (immune HR per SD = 1.58, 95% CI 1.25–2.00; cell-cycle HR = 1.47, 95% CI 1.15–1.89). Crucially, interaction analyses indicated that the prognostic impact of these signatures did not significantly differ between sexes, demonstrating consistent adverse associations across both male and female cohorts. Conclusion: Immune and cell cycle transcriptional programs show robust, independent associations with survival in lower grade glioma that are consistent across sexes. Elevated activity in either pathway is universally linked to poorer outcomes. These findings validate the broad prognostic utility of these transcriptional signatures in LGG, highlighting their potential clinical relevance regardless of patient sex.
- Open Access
- 28 May 2026
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 27
Enhanced Measures to Quantify Gait and Balance Impairment in Degenerative Cervical Myelopathy: A Prospective Cohort Study
- 28 May 2026
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 27
Open AccessEnhanced Measures to Quantify Gait and Balance Impairment in Degenerative Cervical Myelopathy: A Prospective Cohort Study
- Open Access
- 8 May 2026
- Published by Elsevier in World Neurosurgery
- Vol. 211, 125041
Metastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features
- 8 May 2026
- Published by Elsevier in World Neurosurgery
- Vol. 211, 125041
Open AccessMetastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features
- Open Access
- 18 January 2026
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 40 (4) , 1-12
Surgical management of ossified posterior longitudinal ligament: a review
Ossification of the posterior longitudinal ligament (OPLL) is a progressive disorder characterized by abnormal ectopic bone formation along the posterior longitudinal ligament, often leading to spinal canal stenosis and cervical myelopathy. OPLL is increasingly recognized worldwide due to advancements in imaging technology. Surgical management remains the mainstay of treatment for symptomatic patients, but the optimal approach continues to be debated. This review aims to provide a practical workflow based on the current evidence on the pathophysiology, classification, diagnostic imaging, and the surgical management of OPLL, while highlighting the advantages, limitations, and outcomes of anterior, posterior, and combined approaches. Evidence indicates that surgical management significantly improves neurological function in symptomatic patients. Anterior approaches provide direct decompression and correction of cervical alignment but are associated with higher complication rates such as CSF leaks and dysphagia. Posterior approaches allow for indirect decompression and wider canal expansion, though they may predispose to kyphosis and OPLL progression. Laminoplasty offers motion preservation but carries a risk of disease progression. Patient selection guided by factors such as canal occupancy ratio, cervical alignment, and K-line status is critical in optimizing outcomes. However, surgical decision-making in OPLL must be individualized, balancing disease severity, anatomical considerations, and long-term risks. Further prospective studies are warranted to refine surgical guidelines and improve long-term outcomes, especially when new technologies such as robotics or augmented reality are used.
- 18 January 2026
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 40 (4) , 1-12
Open AccessSurgical management of ossified posterior longitudinal ligament: a review
Ossification of the posterior longitudinal ligament (OPLL) is a progressive disorder characterized by abnormal ectopic bone formation along the posterior longitudinal ligament, often leading to spinal canal stenosis and cervical myelopathy. OPLL is increasingly recognized worldwide due to advancements in imaging technology. Surgical management remains the mainstay of treatment for symptomatic patients, but the optimal approach continues to be debated. This review aims to provide a practical workflow based on the current evidence on the pathophysiology, classification, diagnostic imaging, and the surgical management of OPLL, while highlighting the advantages, limitations, and outcomes of anterior, posterior, and combined approaches. Evidence indicates that surgical management significantly improves neurological function in symptomatic patients. Anterior approaches provide direct decompression and correction of cervical alignment but are associated with higher complication rates such as CSF leaks and dysphagia. Posterior approaches allow for indirect decompression and wider canal expansion, though they may predispose to kyphosis and OPLL progression. Laminoplasty offers motion preservation but carries a risk of disease progression. Patient selection guided by factors such as canal occupancy ratio, cervical alignment, and K-line status is critical in optimizing outcomes. However, surgical decision-making in OPLL must be individualized, balancing disease severity, anatomical considerations, and long-term risks. Further prospective studies are warranted to refine surgical guidelines and improve long-term outcomes, especially when new technologies such as robotics or augmented reality are used.
- Open Access
- 15 December 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (24)
Minimally invasive tubular retractor implantation of a paddle electrode stimulator for the trigeminal nucleus caudalis: illustrative case
BACKGROUND: Paddle electrode stimulation of the trigeminal nucleus caudalis (TNC) for refractory craniofacial pain syndromes provides improved coverage and has lower migration rates than cylindrical leads; however, paddle implantation requires open surgery, which can cause significant pain and limit use in high-risk patients. Herein, the authors present a minimally invasive (MIS) approach, adapting the use of tubular retractors for MIS spine surgery and therefore minimizing the surgical morbidity of paddle electrode implantation at the craniocervical junction. OBSERVATIONS: An 81-year-old man with postherpetic trigeminal neuropathy in the left V1 and V2 distribution underwent paddle lead implantation via a 2.5-cm occipitocervical incision and a tubular retractor system. The patient experienced a reduction in pain (from a visual analog scale score of 9/10 to 2/10), without any postoperative complications. LESSONS: This technical report demonstrates the feasibility of implanting paddle electrodes via an MIS tubular retractor system for stimulating the TNC. The approach minimizes soft tissue disruption, reduces postoperative pain, and offers a viable alternative to open surgery, which is especially useful for medically complex patients requiring neuromodulation for craniofacial pain. https://thejns.org/doi/10.3171/CASE25721
- 15 December 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (24)
Open AccessMinimally invasive tubular retractor implantation of a paddle electrode stimulator for the trigeminal nucleus caudalis: illustrative case
BACKGROUND: Paddle electrode stimulation of the trigeminal nucleus caudalis (TNC) for refractory craniofacial pain syndromes provides improved coverage and has lower migration rates than cylindrical leads; however, paddle implantation requires open surgery, which can cause significant pain and limit use in high-risk patients. Herein, the authors present a minimally invasive (MIS) approach, adapting the use of tubular retractors for MIS spine surgery and therefore minimizing the surgical morbidity of paddle electrode implantation at the craniocervical junction. OBSERVATIONS: An 81-year-old man with postherpetic trigeminal neuropathy in the left V1 and V2 distribution underwent paddle lead implantation via a 2.5-cm occipitocervical incision and a tubular retractor system. The patient experienced a reduction in pain (from a visual analog scale score of 9/10 to 2/10), without any postoperative complications. LESSONS: This technical report demonstrates the feasibility of implanting paddle electrodes via an MIS tubular retractor system for stimulating the TNC. The approach minimizes soft tissue disruption, reduces postoperative pain, and offers a viable alternative to open surgery, which is especially useful for medically complex patients requiring neuromodulation for craniofacial pain. https://thejns.org/doi/10.3171/CASE25721
- Open Access
- 11 September 2025
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 49 (6) , 528-536
Understanding glioma pathogenesis through ultrastructural analysis
Gliomas arise from glial cells and make up to 85% of malignant brain tumors, with an average survival of only 15 months for glioblastoma. Advances in our understanding of glioma pathogenesis and treatment require a critical analysis of the tumor ultrastructure and its microenvironment. Ultrastructural analysis (UA) using high-resolution electron microscopy enables crucial insights into the cellular and subcellular characteristics of gliomas, revealing organelle abnormalities and confirming molecular alterations. We focus on recent developments in our understanding of the ultrastructural pathology of gliomas that show the abundance of lipids found in both intracellular and extracellular environments. These lipid changes are associated with aberrant structures of mitochondria and even the disappearance of cellular membranes. Significant disruptions were also noted in tumors' blood vessels and intriguing details emerged about neovascularization and the atypical content and structure of vessel walls. In a typical display of mimicry, tumor cells replaced endothelial cells on the luminal wall of the vessels. Recent UA findings also detected multinucleated giant cells in high prevalence with the presence of extrachromosomal DNA in the microenvironment. Finally, we provide an overview of the implications of UA findings regarding future research, diagnostic modalities, and therapeutic options.
- 11 September 2025
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 49 (6) , 528-536
Open AccessUnderstanding glioma pathogenesis through ultrastructural analysis
Gliomas arise from glial cells and make up to 85% of malignant brain tumors, with an average survival of only 15 months for glioblastoma. Advances in our understanding of glioma pathogenesis and treatment require a critical analysis of the tumor ultrastructure and its microenvironment. Ultrastructural analysis (UA) using high-resolution electron microscopy enables crucial insights into the cellular and subcellular characteristics of gliomas, revealing organelle abnormalities and confirming molecular alterations. We focus on recent developments in our understanding of the ultrastructural pathology of gliomas that show the abundance of lipids found in both intracellular and extracellular environments. These lipid changes are associated with aberrant structures of mitochondria and even the disappearance of cellular membranes. Significant disruptions were also noted in tumors' blood vessels and intriguing details emerged about neovascularization and the atypical content and structure of vessel walls. In a typical display of mimicry, tumor cells replaced endothelial cells on the luminal wall of the vessels. Recent UA findings also detected multinucleated giant cells in high prevalence with the presence of extrachromosomal DNA in the microenvironment. Finally, we provide an overview of the implications of UA findings regarding future research, diagnostic modalities, and therapeutic options.